| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.4M | — | +13.6% |
| Cost of Revenue | $6.5M | — | +4.2% |
| Gross Profit | $6.9M | — | +24.2% |
| R&D Expense | $3.5M | — | -9.3% |
| SG&A Expense | $9.9M | — | -3.2% |
| Operating Income | -$12.9M | — | -16.9% |
| Net Income | -$12.0M | — | -127.4% |
| EPS (Basic) | -$0.32 | — | -126.0% |
| EPS (Diluted) | -$0.32 | — | -126.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $67.6M | -4.2% | -14.7% |
| Short-term Investments | $44.2M | +4.1% | -2.2% |
| Accounts Receivable | $9.9M | -12.9% | +42.4% |
| Inventory | $13.2M | +1.9% | +3.9% |
| Current Assets | $142.0M | -1.8% | -4.7% |
| Total Assets | $186.7M | -1.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.2M | — | +108.0% |
| Capital Expenditures | $40K | — | -74.8% |
| Investing Cash Flow | -$2.0M | — | -104.0% |
| Financing Cash Flow | -$2.2M | — | -1047.1% |
| Free Cash Flow | $1.2M | — | +107.7% |
| -4.8% |
| Current Liabilities | $39.7M | +16.4% | +102.8% |
| Total Liabilities | $52.5M | +13.3% | +43.5% |
| Stockholders' Equity | $134.2M | -6.6% | -15.8% |